ALAMEDA, Calif., Sept. 3, 2019 /PRNewswire/ — Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality. The platform debuts September 3rd, 2019 at the World Molecular Imaging Congress (WMIC) in Montreal, Canada.
The MOMENTUM MPI system can now be installed as a base system or with an integrated CT module. The MPI is currently used to investigate new cell therapy treatments, immunology and cancer in preclinical research models. The technology quantitatively detects magnetic nanoparticles tracers anywhere in the body with exceptional contrast, sensitivity, and resolution to image functional events in the body. While MPI offers high contrast detection of functional events in the body such as cell trafficking to disease sites and inflammation, it does not image anatomical structures. By integrating CT, researchers will have the ability to identify precise locations of these events based on tissue and bone structures.